AOD-9604 (Fragment 176-191)

Evidence: ★★☆☆☆ · Status: Not Approved

In plain English

Just the fat-burning tail of growth hormone, without the muscle/blood-sugar effects. Popular for fat loss; human evidence is thin.

How it works

C-terminal fragment of GH proposed to stimulate lipolysis and inhibit lipogenesis without GH's glucose/IGF effects — the "fat-loss fragment."

Molecular target & official sources

GH1 growth hormone (NCBI Gene) · AOD-9604 (PubChem)

Bottom line

Plausible lipolytic; weak human data.

Helps with: Build Muscle & Strength · Lose Fat · Hormones & Testosterone

Stacks with

Shares a pathway — often paired with: EPO (Erythropoietin), Tesamorelin (Egrifta), Human Growth Hormone (Somatropin), Insulin (anabolic misuse).

Availability & where to buy

Not widely approved. Not approved for general sale in most markets (Singapore included). Grey-market only — dose, purity and legality uncertain.

How it works: the PI3K/Akt growth factor pathway →